封面
市場調查報告書
商品編碼
2128848

醫療設備銷售協議(2016年至2026年)

Distribution Deals in Medical Devices 2016 to 2026

出版日期: | 出版商: Current Partnering | 英文 250+ Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

醫療設備銷售合約(2016年至2026年)

讓我們了解醫療設備公司如何建立銷售合作夥伴關係,以擴大其分銷網路、進入新市場,並將產品交付給世界各地的醫療保健相關人員。

《醫療設備銷售協議》提供了 599 項涉及醫療設備製造商和產品的銷售合作關係的全面資訊。

銷售夥伴關係是醫療設備業將產品推向市場的重要手段,它使製造商能夠利用已建立的銷售管道、區域專業知識、醫療保健客戶和本地市場能力,而無需在每個地區建立完整的銷售基礎設施。

本報告不僅檢驗了獨立的銷售協議,還檢視了納入更廣泛的合作協議中的銷售權,深入分析了醫療設備公司為擴大其產品的商業化和地域覆蓋範圍而採取的各種方法。

本報告不僅限於列舉交易案例;它還能幫助用戶了解哪些公司正在建立銷售合作夥伴關係,協議的結構如何,哪些公司特別活躍,以及可以從披露的財務條款和公開的合約文件中了解到什麼。

本報告為參與建立和管理醫療設備銷售合作夥伴關係的業務發展、商業策略、市場准入、國際營運、合作夥伴關係管理以及法律負責人提供實用見解和基準資源。

了解醫療設備銷售的現況。

本報告分析了2016年至2026年的銷售合約簽訂趨勢,內容包括:

  • 銷售交易的年度趨勢
  • 合作關係發展階段
  • 治療區域
  • 技術類型
  • 大多數活躍公司都在簽署銷售協議
  • 獨立銷售合約的特點
  • 多因素合約中的銷售權
  • 根據已披露的交易金額,主要交易
  • 醫療設備銷售策略的演變
  • 這使用戶能夠了解銷售活動集中在哪些方面,並識別在相關醫療設備產品和技術的商業化方面擁有良好業績記錄的公司。
  • 了解醫療設備銷售合約的結構
  • 銷售協議必須明確規定銷售區域、權利、責任以及製造商與其商業夥伴之間產品供應和銷售的實際框架。

本報告提供以下信息,幫助使用者探索以下領域:

  • 地理和區域權利
  • 獨家銷售和非獨家銷售
  • 銷售和行銷職責
  • 關於產品供應的安排
  • 定價和支付規定
  • 最低採購量或最低履約義務
  • 關於監管和市場准入的責任
  • 關於產品註冊和商業化的義務
  • 智慧財產權和品牌相關法規
  • 合作夥伴之間的商業責任
  • 合約期限和終止條款
  • 如已揭露財務狀況
  • 此外,本報告檢驗了銷售權作為更廣泛合作關係的一部分的安排,幫助用戶了解銷售如何與許可、供應、開發和其他合作關係要素相互作用。
  • 尋找有潛力的銷售夥伴
  • 對於進入新市場的醫療設備製造商而言,找到具有市場影響力、產品專業知識和商業性能力的經銷商至關重要。
  • 本報告列出了 25 家最活躍的銷售公司,並提供交易歷史記錄,以幫助您調查在醫療設備銷售領域擁有良好業績記錄的公司。

這使得以下情況成為可能:

  • 確定銷售代理商和合作夥伴
  • 對潛在商業夥伴的評估
  • 進入國際市場
  • 競爭對手分析
  • 商業化計劃
  • 打入市場策略
  • 過去的銷售業績可以為識別那些對特定醫療設備技術、治療領域和市場有堅定承諾的公司提供有用的線索。
  • 關鍵交易和已揭露財務狀況的基準分析
  • 本報告根據已揭露的交易額,確定了關鍵的醫療設備銷售交易,並提供了與每份合約相關的可用財務和商業資訊。
  • 如果條款公開,使用者可以將這些交易作為參考,研究類似合作關係的結構,並評估潛在的銷售協議。
  • 從實際合約文件中學習
  • 本報告在有相關銷售合約文件的情況下,提供查閱該文件的途徑。
  • 這些合約揭示了僅憑公司新聞稿無法獲得的詳細信息,使用戶能夠檢驗選定的醫療設備公司如何處理銷售區域、獨家經銷權、供應、定價、最低購買義務、商業化責任和合約終止等問題。
  • 對於準備和談判銷售協議的團隊來說,這些實際合約提供了關於類似交易如何實際記錄的寶貴見解。
  • 醫療設備銷售合約綜合目錄
  • 本報告包含 599 項醫療設備銷售交易的綜合目錄,使用戶能夠找到與其產品、技術和商業性目標相關的交易。

交易記錄可依以下類別查看:

  • 公司
  • 治療區域
  • 技術類型
  • 合約揭露狀態
  • 每筆交易都與其底層交易記錄相關聯,從而可以存取詳細的交易資訊和相關的合約文件(如有)。
  • 誰該使用這份報告?
  • 業務拓展團隊
  • 確定潛在經銷商、相關的過往交易和類似商業性安排。
  • 商業策略和市場准入團隊
  • 本報告探討了醫療設備公司如何利用銷售夥伴關係關係來擴大產品覆蓋範圍並進入新市場。
  • 國際和區域專案團隊
  • 我們尋找在醫療設備銷售方面擁有良好業績記錄的組織,並協助他們制定市場進入計劃。
  • 醫療設備製造商尋求業務合作夥伴
  • 我們將調查相關技術、產品領域以及已活躍於市場上的潛在經銷商。
  • 合作關係管理團隊
  • 在類似的協議中,我們將仔細審查商業責任、供應鏈以及合作夥伴的持續義務。
  • 法律及交易團隊
  • 我們仔細審查合約結構和公開的合約條款,以協助交易準備和談判。
  • 競爭情報與市場情報團隊
  • 我們按公司、治療領域和技術追蹤銷售趨勢,以了解不斷變化的商業化策略。
  • 我們將整體市場資訊轉化為針對每家公司的具體洞察。
  • 對於符合資格的客戶,Current Partnering 不僅會提供報告,還會提供客製化的高階主管合作夥伴簡報。
  • 本次簡報將協助您將有關銷售基礎醫療設備的資訊應用到您自己的產品、技術、目標市場或商業性目標。
  • 如有需要,我們可以提供相關的類似交易、潛在銷售合作夥伴、競爭對手趨勢、業務結構、財務基準、合約見解以及其他專為您情況選擇的資訊。
  • 請索取樣本或聯繫 Current Partnering 以了解更多關於本報告的信息,以及我們是否可以為貴公司提供客製化分析。

目錄

執行摘要

第1章:引言

第2章 銷售交易趨勢

  • 介紹
  • 銷售合約的定義
  • 銷售交易趨勢
  • 簽訂銷售夥伴關係協議的原因

第3章:銷售交易結構概述

  • 介紹
  • 銷售代理協議的結構

第4章 主要銷售交易

  • 介紹
  • 按以金額為準的前幾筆銷售交易

第5章:25位最活躍的交易員

  • 介紹
  • 銷售業中最活躍的25家交易公司
  • 特價優惠列表
  • 交易目錄 - 按公司 AZ 分類的銷售交易
  • 交易目錄 - 按治療領域分類的銷售交易
  • 交易目錄 - 按技術類型分類的銷售交易
  • 關於 Biopharma Research Ltd.
  • Current Partnering
  • 目前合約
  • 最新報告標題
簡介目錄
Product Code: CP2052m

Distribution Deals in Medical Devices 2016-2026

Understand how medical device companies structure distribution partnerships to expand commercial reach, enter new markets and bring products to healthcare customers worldwide.

Distribution Deals in Medical Devices provides comprehensive intelligence on 599 distribution deals involving medical device companies and products.

Distribution partnerships are an important route to commercialization in the medical device sector, enabling manufacturers to access established sales channels, regional expertise, healthcare customers and local market capabilities without building a complete commercial infrastructure in every territory.

The report examines both standalone distribution agreements and distribution rights incorporated within wider partnering arrangements, providing insight into the different approaches medical device companies use to commercialize products and expand geographic reach.

Rather than simply identifying transactions, the report enables users to understand who is entering distribution partnerships, how agreements are structured, which companies are particularly active, and what can be learned from disclosed financial terms and publicly available contract documents.

It provides a practical intelligence and benchmarking resource for business development, commercial strategy, market access, international business, alliance management and legal teams involved in establishing or managing medical device distribution partnerships.

Understand the medical device distribution landscape

The report analyzes distribution dealmaking from 2016 to 2026, including:

  • Trends in distribution dealmaking by year
  • Phase of development at the time of partnering
  • Therapy area
  • Technology type
  • Most active distribution dealmakers
  • Attributes of standalone distribution deals
  • Distribution rights within multi-component agreements
  • Leading deals by disclosed value
  • How medical device distribution strategies are evolving
  • This enables users to understand where distribution activity is concentrated and identify companies with demonstrated experience in commercializing relevant medical device products and technologies.
  • Understand how medical device distribution agreements are structured
  • Distribution agreements require manufacturers and their commercial partners to define territories, rights, responsibilities and the practical framework through which products will be supplied and sold.

The report provides intelligence to help users examine areas including:

  • Geographic and territorial rights
  • Exclusive and non-exclusive distribution
  • Sales and marketing responsibilities
  • Product supply arrangements
  • Pricing and payment provisions
  • Minimum purchase or performance commitments
  • Regulatory and market access responsibilities
  • Product registration and commercialization obligations
  • Intellectual property and branding provisions
  • Commercial responsibilities between partners
  • Term and termination provisions
  • Financial terms where disclosed
  • The report also examines arrangements where distribution rights form part of a broader alliance, helping users understand how distribution can interact with licensing, supply, development and other partnership components.
  • Identify prospective distribution partners
  • For medical device companies entering new territories, identifying a distributor with relevant market presence, product expertise and commercial capabilities can be critical.
  • The report identifies the Top 25 most active distribution dealmakers and provides transaction histories that can help users investigate companies with established involvement in medical device distribution.

This can support:

  • Distributor and partner identification
  • Assessment of potential commercial partners
  • International market expansion
  • Competitor analysis
  • Commercialization planning
  • Market-entry strategy
  • Previous distribution activity can provide useful evidence of companies with an established appetite for particular device technologies, therapeutic areas and markets.
  • Benchmark leading deals and disclosed financial terms
  • The report identifies leading medical device distribution transactions by disclosed deal value and provides access to available financial and commercial information associated with individual agreements.
  • Where terms have been disclosed, users can investigate how comparable partnerships have been structured and use these transactions as reference points when evaluating potential distribution arrangements.
  • Learn from real-world contract documents
  • Where publicly available, the report provides access to underlying distribution contract documents.
  • These agreements can reveal substantially more detail than company announcements alone, allowing users to examine how selected medical device companies have addressed issues such as territory, exclusivity, supply, pricing, minimum commitments, commercialization responsibilities and termination.
  • For teams preparing for or negotiating a distribution agreement, these real-world contracts provide valuable insight into how comparable transactions have been documented in practice.
  • Comprehensive medical device distribution deal directory
  • The report includes a comprehensive directory of 599 medical device distribution deals, enabling users to identify transactions relevant to their own products, technologies and commercial objectives.

Deals can be reviewed by:

  • Company
  • Therapy area
  • Technology type
  • Contract availability
  • Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
  • Who should use this report?
  • Business Development teams
  • Identify prospective distributors, relevant precedent transactions and comparable commercial arrangements.
  • Commercial Strategy and Market Access teams
  • Understand how medical device companies use distribution partnerships to extend product reach and access new markets.
  • International and Regional Business teams
  • Identify organizations with demonstrated medical device distribution experience and support market-entry planning.
  • Medical Device Companies Seeking Commercial Partners
  • Investigate potential distributors already active in related technologies, product areas and markets.
  • Alliance Management teams
  • Examine commercial responsibilities, supply arrangements and ongoing partner obligations within comparable agreements.
  • Legal and Transaction teams
  • Review agreement structures and publicly available contract language to support deal preparation and negotiation.
  • Competitive and Market Intelligence teams
  • Track distribution activity by company, therapy area and technology to understand evolving commercialization strategies.
  • Turn market-wide intelligence into company-specific insight
  • For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
  • The briefing applies the underlying medical device distribution intelligence to the customer's own products, technologies, target markets or commercial objectives.
  • Depending on requirements, this can include relevant comparable transactions, prospective distribution partners, competitor activity, commercial structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
  • Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in distribution dealmaking

  • 2.1. Introduction
  • 2.2. Definition of distribution deal
  • 2.3. Trends in distribution deals
    • 2.3.1. Distribution dealmaking by year
    • 2.3.2. Distribution dealmaking by phase of development
    • 2.3.3. Distribution dealmaking by therapy area
    • 2.3.4. Distribution dealmaking by technology type
    • 2.3.5. Distribution dealmaking by most active company
  • 2.4. Reasons for entering into distribution partnering deals

Chapter 3 - Overview of distribution deal structure

  • 3.1. Introduction
  • 3.2. Distribution agreement structure

Chapter 4 - Leading distribution deals

  • 4.1. Introduction
  • 4.2. Top distribution deals by value

Chapter 5 - Top 25 most active distribution dealmakers

  • 5.1. Introduction
  • 5.2. Top 25 most active distribution dealmakers
  • Deal directory
  • Deal directory - distribution dealmaking by companies A-Z
  • Deal directory - distribution dealmaking by therapy area
  • Deal directory - distribution dealmaking by technology type
  • About Biopharma Research
  • Current Partnering
  • Current Agreements
  • Recent report titles from Current Partnering

TABLE OF FIGURES

  • Figure 1: Definition of distribution
  • Figure 2: Trends in distribution deal announcements
  • Figure 3: Distribution deals signed at each phase of development
  • Figure 4: Distribution deals by therapy area
  • Figure 5: Distribution deals by technology type
  • Figure 6: Top 25 most active distribution dealmakers
  • Figure 7: Issues in implementing distribution agreements
  • Figure 8: Distribution agreements - what should a contract include?
  • Figure 9: Components of the distribution deal structure
  • Figure 10: Top distribution deals by value
  • Figure 11: Most active distribution dealmakers